Showing 561-570 of 18560 results for "".
AIP Emerges as a Potential Marker for Diabetic Kidney Risk
https://reachmd.com/programs/clinicians-roundtable/aip-emerges-as-a-potential-marker-for-diabetic-kidney-risk/37220/Rethinking MacTel: Cell-based Insights for Vision Preservation
https://reachmd.com/programs/cme/Rethinking-MacTel-Cell-Based-Insights-for-Vision-Preservation/35524/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.VNS Therapy Achieves Cost Neutrality Within 2 Years Across All US Payer Types
https://practicalneurology.com/meeting-coverage/aes-2025/vns-therapy-achieves-cost-neutrality-within-2-years-across-all-us-payer-types/49194/What is the Safety of Statins in Patients with Diabetes?
https://reachmd.com/programs/lipid-luminations/what-is-the-safety-of-statins-in-patients-with-diabetes/6967/At the most recent National Lipid Association (NLA) meeting, host Dr. Alan Brown welcomes Kevin Maki, PhD, FNLA, CLS, Chief Science Officer for Midwest Center for Metabolic and Cardiovascular Research and Adjunct Faculty position in Biostatistics and Applied Epidemiology at DePaul University, ChicagToward Precision Medicine for Genetic Epilepsies: Glucose Transporter Type 1 Deficiency Syndrome
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/toward-precision-medicine-for-genetic-epilepsies-glucose-transporter-type-1-deficiency-syndrome/32055/As we begin to understand the mechanisms of specific genetic epilepsies, tailored treatments have the potential to be transformative, as in GLUT1-DS.Update on Diabetic Gastroparesis
https://reachmd.com/programs/clinicians-roundtable/update-on-diabetic-gastroparesis/1870/Dr. William Chey reviews newer thinking on the pathophysiology and treatment of this difficult disorder.Advances in Therapy for Neovascular AMD and Diabetic Eye Disease
https://evolvemeded.com/specialty/retina/2507_advances-in-therapy-for-neovascular-amd-and-diabetic-eye-disease/32458/Drs. Sheth and Regillo outline the most recent innovations in anti-VEGF formulations, pipeline therapies, and how these advances benefit patients.Breaking Down the Bionic Pancreas: A Device for Dosing Decisions for T1D
https://reachmd.com/programs/diabetes-discourse/breaking-down-the-bionic-pancreas-a-device-for-dosing-decisions-for-t1d/14229/Can the bionic pancreas measure carbs, monitor blood sugar levels, and lower A1c for patients with type 1 diabetes? Find out.Sports related brain injuries
https://reachmd.com/programs/clinicians-roundtable/sports-related-brain-injuries/7/Pulmonologist, Dr. Ankin, discusses the types and prevalence of sports related brain injuries and sleep disorder breathing.Investigating T2 Inflammation in Severe Asthma & COPD
https://reachmd.com/programs/deep-breaths-updates-chest/investigating-t2-inflammation-in-severe-asthma-copd/13424/Find out how to identify type 2 inflammation in patients with severe asthma and COPD.